NO prodrug-conjugated, self-assembled, pH-responsive and galactose receptor targeted nanoparticles for co-delivery of nitric oxide and doxorubicin-Reference-Cited by-同舟云学术

NO prodrug-conjugated, self-assembled, pH-responsive and galactose receptor targeted nanoparticles for co-delivery of nitric oxide and doxorubicin

Published:2018 Issue:9 Volume:10 Page:4179-4188
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Zhang Jimin¹²³⁴⁵,Song Huijuan⁶⁷⁸⁹,Ji Shenglu¹²³⁴⁵,Wang Xiaomin¹²³⁴⁵,Huang Pingsheng⁶⁷⁸⁹^ORCID,Zhang Chuangnian⁶⁷⁸⁹,Wang Weiwei⁶⁷⁸⁹^ORCID,Kong Deling¹²³⁴⁵^ORCID

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology

2. Key Laboratory of Bioactive Materials

3. Ministry of Education

4. Collaborative Innovation Center of Chemical Science and Engineering (Tianjin)

5. College of Life Sciences

6. Institute of Biomedical Engineering

7. Chinese Academy of Medical Sciences & Peking Union Medical College

8. Tianjin 300192

9. PR China

Abstract

Nitric oxide (NO) prodrug-conjugated, acid-responsive and galactose receptor targeted nanoparticles were developed for the co-delivery of NO and doxorubicin.

Funder

National Natural Science Foundation of China

Chinese Academy of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NR/C7NR08176F

Reference48 articles.

1. Nobel Prize Awarded to Scientists for Nitric Oxide Discoveries

2. Nitric Oxide Donors for Cardiovascular Implant Applications